UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Genpact Limited (NYSE:G - Free Report) by 308.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 455,070 shares of the business services provider's stock after acquiring an additional 343,752 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.26% of Genpact worth $19,545,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Blue Trust Inc. increased its stake in Genpact by 8.7% during the fourth quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after acquiring an additional 441 shares during the last quarter. KBC Group NV acquired a new stake in shares of Genpact during the 4th quarter worth about $298,000. State of New Jersey Common Pension Fund D purchased a new stake in Genpact in the 4th quarter valued at about $2,030,000. Pictet Asset Management Holding SA purchased a new stake in Genpact in the 4th quarter valued at about $921,000. Finally, Proficio Capital Partners LLC acquired a new position in Genpact in the fourth quarter valued at about $983,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Insider Buying and Selling at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This trade represents a 4.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction on Tuesday, May 13th. The shares were purchased at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the acquisition, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is owned by insiders.
Genpact Stock Down 0.7%
G stock traded down $0.28 during midday trading on Monday, hitting $42.77. The company's stock had a trading volume of 1,238,520 shares, compared to its average volume of 1,374,356. The firm has a 50-day simple moving average of $46.60 and a 200-day simple moving average of $47.30. The firm has a market capitalization of $7.48 billion, a P/E ratio of 15.06, a PEG ratio of 1.84 and a beta of 1.02. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.73 EPS. As a group, equities analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Analyst Ratings Changes
G has been the topic of a number of research analyst reports. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho lifted their target price on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC cut their target price on Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a research report on Thursday, May 8th. Finally, Robert W. Baird dropped their price objective on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $50.71.
Check Out Our Latest Research Report on Genpact
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Read More

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.